Response to Brentuximab Vedotin and Quality of Life in Patients with Relapsed/Refractory Hodgkin Lymphoma (RR HL) in the Real World Setting

Authors :: Ionova, Tatyana
Afanasiev, Boris
Andrievskih, Maria
Amdiev, Alim
Baryakh, Elena A.
Chang, Viktor
Husainova, Gulnara
Ivanov, Vladimir
Kaplanov, Kamil D
Kaverina, Oksana
Klitochenko, Tatiana
Kurakin, Vyacheslav
Larionova, Olga
Lazareva, Darya
Lepik, Kirill
Lysenko, Irina
Mikhailova, Nataliia
Minullina, Raisa
Mironov, Oleg
Misyurina, Elena
Mochkin, Nikita
Nikitina, Tatiana
Osipov, Iurii
Petrova, Tatiana
Porfirieva, Natalia
Rykavitcin, Oleg
Safin, Rustem
Shelekhova, Tatiana
Sherstnev, Dmitrij
Simashova, Polina
Smirnova, Elena
Trenina, Natalia
Vasiliev, Evgeniy V.
Volkov, Mikhail
Volodicheva, Elena
Source :: Blood; November 2019, Vol. 134 Issue: Supplement 1 p5296-5296, 1p
Publication Year :: 2019
Abstract: Ionova: Takeda, BMS: Other: Principal Investigator of IISR, Research Funding. Baryakh:Takeda: Consultancy, Honoraria, Speakers Bureau.

Full Text Access

Tools